Literature DB >> 6291767

Regulation of the synthesis of extracellular matrix components in chondroblasts transformed by a temperature-sensitive mutant of Rous sarcoma virus.

S L Adams, D Boettiger, R J Focht, H Holtzer, M Pacifici.   

Abstract

Regulation of cartilage extracellular matrix synthesis has been examined in chondroblasts infected with a temperature-sensitive mutant of Rous sarcoma virus. Cells grown at the nonpermissive temperature synthesized large amounts of several chondroblast-specific polypeptides (type IV proteoglycan core protein, type II procollagen, a proteoglycan link protein(s) and a 60 kd protein) and very low levels of fibronectin. At the permissive temperature, synthesis of chondroblast-specific proteins was coordinately reduced, while fibronectin synthesis was greatly increased. These changes reflected comparable alterations in levels of translatable mRNAs encoding these proteins. This analysis also revealed the unexpected presence in the transformed cells of type I collagen mRNAs, which are not used in intact cells, indicating that a posttranscriptional control (or controls) may be acting in transformed chondroblasts.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291767     DOI: 10.1016/0092-8674(82)90235-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  33 in total

1.  Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors.

Authors:  D G Stokes; G Liu; R Dharmavaram; D Hawkins; S Piera-Velazquez; S A Jimenez
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

2.  Expression of v-src in embryonic neural retina alters cell adhesion, inhibits histogenesis, and prevents induction of glutamine synthetase.

Authors:  L Vardimon; L E Fox; R Cohen-Kupiec; L Degenstein; A A Moscona
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

3.  Association of a change in chromatin structure with a tissue-specific switch in transcription start sites in the alpha 2(I) collagen gene.

Authors:  K M Beck; A H Seekamp; G R Askew; Z Mei; C M Farrell; S Wang; L N Lukens
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

4.  Inhibition of epidermal growth factor receptor biosynthesis caused by the src oncogene product, pp60v-src.

Authors:  W J Wasilenko; M Nori; N Testerman; M J Weber
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

5.  The chick type III collagen gene contains two promoters that are preferentially expressed in different cell types and are separated by over 20 kb of DNA containing 23 exons.

Authors:  Y Zhang; Z Niu; A J Cohen; H D Nah; S L Adams
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

Review 6.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

7.  Control of types I and II collagen and fibronectin gene expression in chondrocytes delineated by viral transformation.

Authors:  E S Allebach; D Boettiger; M Pacifici; S L Adams
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

8.  Transformation by Rous sarcoma virus prevents acetylcholine receptor clustering on cultured chicken muscle fibers.

Authors:  D T Anthony; S M Schuetze; L L Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Effects of chronic renal failure on protein synthesis and albumin messenger ribonucleic acid in rat liver.

Authors:  M A Zern; S H Yap; R K Strair; G A Kaysen; D A Shafritz
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

10.  Changes in osteonectin distribution and levels are associated with mineralization of the chicken tibial growth cartilage.

Authors:  M Pacifici; O Oshima; L W Fisher; M F Young; I M Shapiro; P S Leboy
Journal:  Calcif Tissue Int       Date:  1990-07       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.